Both in Pharmaceuticals
Eli Lilly & vs Vertex Pharmaceuticals
Over the past year LLY returned +56.4% and VRTX returned +30.2%; their daily moves had a correlation of 0.50.
LLY +56.4% VRTX +30.2%Growth of $1, one year, split-adjusted
| Metric | LLY | VRTX |
|---|---|---|
| Price | $1,417.99 | $549.04 |
| Market cap | $1.26T | $139.16B |
| Today | +0.61% | +3.44% |
| 1 month | +22.5% | +9.3% |
| 6 months | +43.7% | +28.4% |
| Year to date | +31.9% | +21.1% |
| 1 year | +58.2% | +28.9% |
| Revenue growth (YoY) | +38.6% | +11.8% |
| Gross margin | 83.9% | 84.7% |
| Net margin | 26.4% | 19.0% |
| P/E (TTM) | 45.8× | 35.0× |
| Price / sales | 14.6× | 10.7× |
| Net cash | -$44.62B | $1.81B |
| Dividend yield | 0.49% | — |
| Volatility (60d) | 29.8% | 28.4% |
| Short % of float | 0.8% | 1.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).